20-羟基二十碳四烯酸可预测急性轻型缺血性卒中神经功能恶化
这项前瞻性多中心观察研究纳入322例急性轻型缺血性卒中患者,入院时检测血浆20-HETE水平,主要终点为入院10天内神经功能恶化(ND)。85例(26.4%)发生ND,平均20-HETE水平为1687±158 pmol/L;多因素分析显示高水平(>1675 pmol/L)20-HETE是ND的独立预测因素,ND与3个月不良预后(mRS 3-6分)风险升高相关。
要点
- 急性轻型缺血性卒中患者10天内ND发生率为26.4%。
- 血浆20-HETE>1675 pmol/L是ND的独立预测因素。
- 发生ND者3个月不良预后(mRS 3-6分)风险更高。
核心结论
- 急性轻型缺血性卒中患者中ND较常见,且与不良预后相关。
- 入院时血浆20-HETE升高可能是急性轻型缺血性卒中发生ND的预测因素。
研究设计与样本
- 前瞻性、多中心观察性研究,纳入急性轻型缺血性卒中患者322例。
- 所有患者入院时检测血浆20-HETE水平,主要终点为入院后10天内ND。
- 入院后3个月采用改良Rankin量表评估残疾程度。
主要发现
- 322例患者中85例(26.4%)发生ND。
- 平均20-HETE水平为1687±158 pmol/L。
- 多因素分析显示高水平(>1675 pmol/L)20-HETE是ND的独立预测因素(第三和第四四分位数)。
- ND与3个月不良预后(mRS 3-6分)风险升高相关。
关键数值与推荐
- 20-HETE高水平定义为>1675 pmol/L,对应第三和第四四分位数。
- ND定义为入院后10天内发生的神经功能恶化。
- 不良预后定义为3个月mRS评分3-6分。
临床怎么用
- 对急性轻型缺血性卒中患者,入院时可检测血浆20-HETE以辅助识别ND高风险者。
- 20-HETE>1675 pmol/L提示需加强神经功能监测。
- 发生ND的患者应关注3个月功能预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The relationship between high plasma 20-hydroxyeicosatetraenoic acid (20-HETE) levels and neurological deterioration (ND) has not been investigated in patients with acute minor ischemic stroke. METHOD: We conducted a prospective, multicenter observational study in patients with acute minor ischemic stroke. Plasma levels of 20-HETE were measured at admission in all patients. The primary end point of the study was ND within 10 days after admission. The degree of disability was assessed using modified Rankin scale at 3 months after admission. RESULTS: A total of 322 patients were enrolled, of which 85 patients (26.4%) developed ND. Mean 20-HETE level was 1687±158 pmol/L. On multivariate analyses, high level (>1675 pmol/L) of 20-HETE was an independent predictor of ND (third and fourth quartiles). Neurological deterioration was associated with a higher risk of poor outcome (modified Rankin scale scores 3-6) at 3 months. CONCLUSIONS: ND is fairly common in acute minor ischemic stroke and is associated with poor prognosis. Elevated plasma level of 20-HETE may be a predictor for ND in acute minor ischemic stroke.
引用
- Yi X, Han Z, Zhou Q, et al. 20-Hydroxyeicosatetraenoic Acid as a Predictor of Neurological Deterioration in Acute Minor Ischemic Stroke. Stroke. 2016. PMID: 27834744
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。